Clinical Study

The Role of the High-Sensitivity C-Reactive Protein in Patients with Stable Non-Cystic Fibrosis Bronchiectasis

Table 1

Demographic data of the 69 stable bronchiectasis patients.

Demographic factorMean (SD)95% CI

Age (years)57.554.2–60.8
BMI (kg/m2)22.021.2–22.8
FVC (L)2.11.9–2.3
FVC% predicted67.462.7–72.0
FEV1 (L)1.51.4–1.7
FEV1% predicted62.657.1–68.1
6 MWD (m)454.4432.4–476.4
Rest O2S%95.194.3–95.9
HRCT score26.223.1–29.3
hs-CRP (mg/L)4.53.6–5.5

Abbreviations: BMI: body mass index, FVC: forced vital capacity, FEV1: volume that has been exhaled at the end of the first second of forced expiration, 6 MWD: 6-minute walk test distance, HRCT: high-resolution computed tomography, and hs-CRP: high-sensitivity C-reactive protein.